Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Equity (2016 - 2025)

Historic Return on Equity for Agios Pharmaceuticals (AGIO) over the last 13 years, with Q4 2025 value amounting to 0.33%.

  • Agios Pharmaceuticals' Return on Equity fell 7600.0% to 0.33% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.33%, marking a year-over-year decrease of 7600.0%. This contributed to the annual value of 0.3% for FY2025, which is 8700.0% down from last year.
  • According to the latest figures from Q4 2025, Agios Pharmaceuticals' Return on Equity is 0.33%, which was down 7600.0% from 0.3% recorded in Q3 2025.
  • In the past 5 years, Agios Pharmaceuticals' Return on Equity ranged from a high of 1.46% in Q4 2021 and a low of 0.52% during Q2 2024
  • Over the past 5 years, Agios Pharmaceuticals' median Return on Equity value was 0.0% (recorded in 2022), while the average stood at 0.23%.
  • Per our database at Business Quant, Agios Pharmaceuticals' Return on Equity surged by 18600bps in 2021 and then crashed by -14300bps in 2022.
  • Quarter analysis of 5 years shows Agios Pharmaceuticals' Return on Equity stood at 1.46% in 2021, then tumbled by -100bps to 0.0% in 2022, then tumbled by -11596bps to 0.42% in 2023, then skyrocketed by 201bps to 0.42% in 2024, then tumbled by -179bps to 0.33% in 2025.
  • Its Return on Equity stands at 0.33% for Q4 2025, versus 0.3% for Q3 2025 and 0.46% for Q2 2025.